Indian Pharma - Live Stock Quotes, Stock Price Update and Analysis from Equitymaster.com
X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Indian Pharma Stocks 

Here are the latest stock price details of India's top Indian Pharma stocks. For more detailed updates, read our Indian Pharma sector report and check the latest Indian Pharma sector results.

» Result Scoreboard | Best Performing Stocks | Refresh
SCRIP BSE PRICE (Rs) NSE PRICE (Rs) CHART MORE INFO
AARTI DRUGS 586.15 0.48% 584.90 -0.28%
 More Info 
AJANTA PHARMA 953.10 -1.53% 954.10 -1.42%
 More Info 
ALEMBIC PHARMA 538.60 -1.57% 539.55 -0.90%
 More Info 
BIOCON LTD 615.85 1.48% 616.15 1.70%
 More Info 
CADILA HEALTHCARE 312.35 0.26% 311.90 0.03%
 More Info 
CIPLA 539.20 -0.40% 539.65 -0.28%
 More Info 
DIVIS LABORATORIES 1,588.50 0.88% 1,587.85 0.83%
 More Info 
GLENMARK PHARMA 579.00 0.45% 579.15 0.36%
 More Info 
INDOCO REMEDIES 176.40 1.41% 174.95 1.07%
 More Info 
IPCA LABS 800.55 -1.10% 804.85 -0.42%
 More Info 
J.B.CHEMICALS 320.20 2.28% 321.05 2.13%
 More Info 
LUPIN LTD 763.25 -1.02% 763.10 -1.01%
 More Info 
NATCO PHARMA 570.35 -0.56% 569.80 -0.93%
 More Info 
NIFTY 50 Not Listed 10,604.35 -0.34%
 More Info 
ORCHID PHARMA LTD 3.24 0.62% 18.90 -2.83%
 More Info 
PANACEA BIOTECH 160.55 0.91% 161.75 0.68%
 More Info 
PIRAMAL ENTERPRISES 2,173.05 0.18% 2,179.60 0.13%
 More Info 
S&P BSE SENSEX 35,352.61 -0.41% Not Listed
 More Info 
STRIDES PHARMA SCIENCE 402.90 -1.20% 404.10 -1.04%
 More Info 
SUN PHARMA 414.35 -0.18% 413.65 -0.24%
 More Info 
TORRENT PHARMA 1,765.15 0.35% 1,763.35 -0.01%
 More Info 
WOCKHARDT LTD. 392.25 0.51% 392.15 0.65%
 More Info 

BSE prices: February 19, 2019  (Close)    NSE prices: February 19, 2019  (Close)

Indian Pharma Stocks Update

The NIFTY PHARMA Index was at 8,543.6 (down 0.4%). The index is down 17.1% over the last 30 days. And over the last 1 year, it has lost 9.1%.

Within the Indian Pharma sector, the top gainers were J.B.CHEMICALS (up 2.3%) and BIOCON LTD (up 1.5%). On the other hand, ALEMBIC PHARMA (down 1.6%) and AJANTA PHARMA (down 1.5%) were among the top losers.

Meanwhile, the benchmark NIFTY 50 was at 10,604.4 (down 0.3%).




Today's Market

Sensex Ends 146 Points Lower; IT and Power Stocks Drag(Closing)

Indian share markets witnessed selling pressure during closing hours and ended their trading session marginally lower.Sectoral indices ended on a mixed note with realty stocks.

Related Views on News

NATCO PHARMA Announces Quarterly Results (3QFY19); Net Profit Down 26.7% (Quarterly Result Update)

Feb 14, 2019 | Updated on Feb 14, 2019

For the quarter ended December 2018, NATCO PHARMA has posted a net profit of Rs 2 bn (down 26.7% YoY). Sales on the other hand came in at Rs 6 bn (down 1.0% YoY). Read on for a complete analysis of NATCO PHARMA's quarterly results.

IPCA LABS Announces Quarterly Results (3QFY19); Net Profit Up 51.7% (Quarterly Result Update)

Feb 14, 2019 | Updated on Feb 14, 2019

For the quarter ended December 2018, IPCA LABS has posted a net profit of Rs 2 bn (up 51.7% YoY). Sales on the other hand came in at Rs 9 bn (up 10.3% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

DIVIS LABORATORIES 2017-18 Annual Report Analysis (Annual Result Update)

Jan 1, 2019 | Updated on Jan 1, 2019

Here's an analysis of the annual report of DIVIS LABORATORIES for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of DIVIS LABORATORIES. Also includes updates on the valuation of DIVIS LABORATORIES.

ALEMBIC PHARMA 2017-18 Annual Report Analysis (Annual Result Update)

Dec 21, 2018 | Updated on Dec 21, 2018

Here's an analysis of the annual report of ALEMBIC PHARMA for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of ALEMBIC PHARMA. Also includes updates on the valuation of ALEMBIC PHARMA.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

The RCom Bankruptcy: 5 Lessons for Smallcap Investors(Profit Hunter)

Feb 7, 2019

Managements of companies can create or ruin their fortunes. Why is management quality such an important factor in valuing businesses? Read on to find out...

The One Real Estate Stock to Buy Now(The 5 Minute Wrapup)

Feb 13, 2019

The real estate sector is ready to make a comeback. This is the stock to consider buying.

How We Pick the Most Profitable Stocks from the Portfolios of Super Investors(The 5 Minute Wrapup)

Feb 8, 2019

This is the trick to following super investors and not losing money.

Small Caps Under Seige: Could This Be A Once-in-a-Decade Wealth Creating Opportunity?(Profit Hunter)

Feb 14, 2019

Don't let the dark clouds hovering over small caps scare you into hiding; it will rain gold as sentiments recover. Indeed, there is a blood bath. And if you are a first time investor, the correction is deep enough to scare you out of markets.

Don't Be Afraid of the Market; Buy Stocks Like This One(The 5 Minute Wrapup)

Feb 14, 2019

During this tough period in the market, a contrarian approach holds huge potential upside for this Smart Money Secrets stock.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

S&P BSE HEALTHCARE


Feb 19, 2019 (Close)

COMPARE COMPANY

MARKET STATS